Kim, Rebecca G.
Ballantyne, April
Lancaster, Elizabeth
Galyean, Patrick
Sharareh, Nasser
Wallace, Andrea
Inadomi, John M.
Zickmund, Susan
Conroy, Molly B.
Price, Jennifer C.
Funding for this research was provided by:
American Association for the Study of Liver Diseases (Clinical, Translational, and Outcomes Research Award)
National Center for Advancing Translational Sciences (NIH Award UM1TR004409)
Article History
Received: 5 February 2026
Accepted: 31 March 2026
First Online: 7 April 2026
Declarations
:
: All research in this study was approved by the Institutional Review Board of the University of Utah and in accordance with the Declaration of Helsinki. Informed consent was collected from each participant prior to (1) completion of any surveys and (2) participation in semi-structured interviews.
: Not applicable.
: A.W. has received travel funds and stipends from NIH study sections and PCORI, as well as honoraria from the AAMC, Northwell Health, and Boston Children’s. J.M.I. is a recipient of a research grant from Exact Sciences. J.C.P. has received research support paid to her institution from AbbVie, Gilead, VIR, and Cepheid. R.G.K., A.B, E.L., P.G., N.S., S.Z., and M.B.C. do not have any disclosures relevant to this manuscript.